TO QUANTIFY AND EVALUATE THE ECONOMIC COST OF BREAST CANCER SURVIVORS THROUGH CROSS-SECTIONAL STUDY Breast cancer is the most common cancer in women worldwide. [1] Breast cancer apart from being a health condition, it is also an economic condition. Economic burden of breast cancer is significant and expected to increase substantially in the future due to medical advancement in treating cancer following cancer diagnosis. [2] In the literature, breast cancer survivors tend to face greater economic cost and productivity loss than persons without cancer history. [3] Breast cancer affects many working age women. [4] This suggests that breast cancer survivors are imperative supporters of the economy. Health-related productivity loss is a critical yet unnoticed component of the economic burden face by these survivors. It has been revealed in literature that indirect costs such as productivity loss and caregiver costs incurred by these breast cancer survivors contribute significantly to the economic cost. However currently there are insufficient local studies conducted to quantify the indirect costs incurred by breast cancer survivors. Thus, this study aims to quantify and evaluate the economic cost of breast cancer survivors. Through the study, we hope health-care policy makers would better understand the needs of the survivors and to develop and prioritise cancer survivorship programs. The economic cost is estimated by collecting medical expenditure data of patients who have completed primary treatment for at least 6 months from the financial database in National Cancer Centre. In addition, the economic cost is also estimated through questionnaire, which collects information about direct costs outside National Cancer Centre and productivity loss due to absenteeism, presenteeism and income loss. These lost time and opportunity will be translated into fiscal terms for quantitative analysis with STATA. REFERENCE: [1] Breast cancer statistics. (n.d.). Retrieved August 04, 2017, from http://www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/breast-cancer-statistics [2] Yabroff, K. R., Lund, J., Kepka, D., & Mariotto, A. (2011, October). Economic Burden of Cancer in the US: Estimates, Projections, and Future Research. Retrieved August 04, 2017, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191884/ [3] Rim, S. H., Guy, G. P., Yabroff, K. R., McGraw, K. A., & Ekwueme, D. U. (2016, October). The impact of chronic conditions on the economic burden of cancer survivorship: a systematic review. Retrieved August 04, 2017, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102793/ [4] Breast Cancer Facts. (n.d.). Retrieved August 04, 2017, from http://www.europadonna.org/breast-cancer-facs/ Ekwueme DU, Trogdon JG, Khavjou OA, Guy GP Jr. Productivity costs associated with breast cancer among survivors aged 18–44 years. American Journal of Preventive Medicine 2016;50(2):286–294. Ekwueme DU, Trogdon JG. The economics of breast cancer in younger women in the U.S.: the present and future. American Journal of Preventive Medicine 2016;50(2):249–254. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1464031/ http://www.sciencedirect.com/science/article/pii/S1098301512000125 http://www.jmcp.org/doi/full/10.18553/jmcp.2017.23.2.136